SPHK2

sphingosine kinase 2

Basic information

Region (hg38): 19:48619290-48630717

Links

ENSG00000063176NCBI:56848OMIM:607092HGNC:18859Uniprot:Q9NRA0AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the SPHK2 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the SPHK2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
4
clinvar
2
clinvar
6
missense
54
clinvar
2
clinvar
3
clinvar
59
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
1
clinvar
1
Total 0 0 54 7 5

Variants in SPHK2

This is a list of pathogenic ClinVar variants found in the SPHK2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
19-48620524-C-A not specified Uncertain significance (Dec 12, 2023)3169019
19-48620528-T-C not specified Uncertain significance (Sep 17, 2021)2251404
19-48625911-C-T Likely benign (Nov 01, 2022)2650212
19-48625917-C-A not specified Uncertain significance (May 21, 2024)3322192
19-48625928-G-C not specified Uncertain significance (Jun 18, 2021)2264550
19-48625961-T-C not specified Uncertain significance (Apr 20, 2024)3322190
19-48625963-G-A not specified Uncertain significance (Mar 15, 2024)3322186
19-48625976-C-T not specified Uncertain significance (Oct 02, 2023)3169022
19-48625997-C-T not specified Uncertain significance (Jan 09, 2024)3169024
19-48626035-G-A not specified Uncertain significance (Feb 12, 2024)3169028
19-48626041-C-T not specified Uncertain significance (Jun 30, 2023)2598929
19-48626060-C-T not specified Uncertain significance (Jul 28, 2021)2279531
19-48626063-C-T not specified Uncertain significance (Jan 29, 2024)3169030
19-48626077-A-C not specified Uncertain significance (Jan 26, 2022)2212598
19-48626084-G-A not specified Uncertain significance (Jun 14, 2022)3169031
19-48626100-T-G Likely benign (Mar 01, 2023)2650213
19-48626113-C-T not specified Uncertain significance (Aug 12, 2021)2384958
19-48626114-G-A not specified Uncertain significance (Jul 14, 2021)2388517
19-48626128-C-G not specified Uncertain significance (Apr 27, 2022)2286460
19-48626143-T-A not specified Uncertain significance (Nov 06, 2023)3169032
19-48626162-G-A not specified Uncertain significance (Dec 14, 2023)3169033
19-48626168-G-A not specified Uncertain significance (Nov 01, 2022)2322004
19-48626233-C-T not specified Uncertain significance (Apr 09, 2024)3322188
19-48626237-G-A not specified Uncertain significance (Feb 16, 2023)2459078
19-48626272-G-T not specified Uncertain significance (Feb 15, 2023)2484855

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
SPHK2protein_codingprotein_codingENST00000245222 611427
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.28e-70.8211256950521257470.000207
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.323584350.8230.00003064022
Missense in Polyphen98146.790.66761308
Synonymous-0.2902112061.030.00001511564
Loss of Function1.481421.40.6550.00000126198

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.001050.00104
Ashkenazi Jewish0.000.00
East Asian0.0001090.000109
Finnish0.0001620.000139
European (Non-Finnish)0.0001670.000158
Middle Eastern0.0001090.000109
South Asian0.0002700.000261
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Catalyzes the phosphorylation of sphingosine to form sphingosine 1-phosphate (SPP), a lipid mediator with both intra- and extracellular functions. Also acts on D-erythro- dihydrosphingosine, D-erythro-sphingosine and L-threo- dihydrosphingosine. Binds phosphoinositides. {ECO:0000269|PubMed:19168031}.;
Pathway
Fc gamma R-mediated phagocytosis - Homo sapiens (human);VEGF signaling pathway - Homo sapiens (human);Calcium signaling pathway - Homo sapiens (human);Apelin signaling pathway - Homo sapiens (human);Tuberculosis - Homo sapiens (human);Sphingolipid signaling pathway - Homo sapiens (human);Phospholipase D signaling pathway - Homo sapiens (human);Sphingolipid metabolism - Homo sapiens (human);Sphingolipid Metabolism;Gaucher Disease;Globoid Cell Leukodystrophy;Metachromatic Leukodystrophy (MLD);Fabry disease;Krabbe disease;Sphingolipid Metabolism;Signal Transduction of S1P Receptor;Metabolism of Spingolipids in ER and Golgi apparatus;Metabolism of lipids;Metabolism;Glycosphingolipid metabolism;Sphingolipid de novo biosynthesis;Sphingolipid metabolism;sphingosine and sphingosine-1-phosphate metabolism;Sphingosine 1-phosphate (S1P) pathway;Ceramide signaling pathway;IL12-mediated signaling events (Consensus)

Recessive Scores

pRec
0.153

Intolerance Scores

loftool
0.795
rvis_EVS
0.13
rvis_percentile_EVS
63.57

Haploinsufficiency Scores

pHI
0.0898
hipred
N
hipred_score
0.272
ghis
0.479

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.996

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Sphk2
Phenotype
cellular phenotype; homeostasis/metabolism phenotype; muscle phenotype; endocrine/exocrine gland phenotype; embryo phenotype; immune system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan);

Zebrafish Information Network

Gene name
sphk2
Affected structure
median fin
Phenotype tag
abnormal
Phenotype quality
blistered

Gene ontology

Biological process
blood vessel development;sphingosine-1-phosphate receptor signaling pathway;sphinganine-1-phosphate biosynthetic process;brain development;female pregnancy;cell population proliferation;positive regulation of cell population proliferation;sphingolipid biosynthetic process;negative regulation of apoptotic process;sphingosine biosynthetic process;lipid phosphorylation
Cellular component
lysosomal membrane;cytosol;membrane;intracellular membrane-bounded organelle
Molecular function
NAD+ kinase activity;protein binding;ATP binding;sphinganine kinase activity;Ras GTPase binding;D-erythro-sphingosine kinase activity;sphingosine-1-phosphate receptor activity